Skip to main content

WELLS FARGO & COMPANY/MN

Position in DSGN — Design Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in DSGN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$96,047
-$155,205 QoQ
Shares Held
9,027
-66.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. DSGN ranks #219 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $96,047 9,027
2025-12-31 $251,252 26,786
2025-09-30 $137,927 18,317
2025-06-30 $68,357 20,284
2025-03-31 $72,745 18,846
2024-12-31 $113,700 18,428
2024-09-30 $77,552 14,415
2024-06-30 $46,219 13,797
2024-03-31 $46,369 11,506
2023-12-31 $26,558 10,022
2023-09-30 $18,955 8,032
2023-06-30 $78,516 12,463
2023-03-31 $34,585 5,994
2022-09-30 $6,788 406
2022-06-30 $6,104 436
2022-03-31 $10,545 653
2021-12-31 $212,879 9,943